Your browser doesn't support javascript.
loading
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
Daher, May; Hidalgo Lopez, Juliana Elisa; Randhawa, Jasleen K; Jabbar, Kausar Jabeen; Wei, Yue; Pemmaraju, Naveen; Borthakur, Gautam; Kadia, Tapan; Konopleva, Marina; Kantarjian, Hagop M; Hearn, Katherine; Estrov, Zeev; Reyes, Steven; Bueso-Ramos, Carlos E; Garcia-Manero, Guillermo.
  • Daher M; Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Hidalgo Lopez JE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Randhawa JK; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Jabbar KJ; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Wei Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Borthakur G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Kadia T; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Hearn K; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Estrov Z; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Reyes S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Bueso-Ramos CE; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Texas, USA.
Am J Hematol ; 92(7): 674-682, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28370157
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Bortezomib / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Bortezomib / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article